MDxHealth (MDXH) Asset Writedowns and Impairment (2025)

MDxHealth has reported Asset Writedowns and Impairment for 3 years, with the latest figure at -$140000.0 in Q1 2026.

• Quarterly Asset Writedowns and Impairment fell 10.24% year-over-year to -$140000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 480.63% YoY) and the FY2025 annual result came in at -$596000.0, down 24.95% from the prior year.
• Asset Writedowns and Impairment retreated to -$140000.0 in Q1 2026 per MDXH's latest filing, from $367000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $3.1 million in Q2 2024 and troughed at -$3.6 million in Q4 2024.
• A 3-year average of -$75400.0 and a median of -$127000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 10.24% in 2026, down 10.24% in 2026.
• Over 3 years, Asset Writedowns and Impairment stood at -$3.6 million in 2024, then surged by 110.17% to $367000.0 in 2025, then plunged by 138.15% to -$140000.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$140000.0, $367000.0, and -$127000.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.